text: Liver transplantation is indicated for patients developing histologiocal evidence of cirrhosis. There is resolution of metabolic derangements after liver transplantation in patients with glycogen storage<unk>  type 3 (GSD 3). As hepatic abnormalities in GSD 3 are due to single-gene and cell-autonomous defect, the recurrence of primary liver<unk>  in the transplanted allograft in not possible. However, skeletal manifestations or cardiac manifestations does not correct even after liver transplantation.
option_0: Glycogen storage disease type III surgery
option_1: Glycogen storage disease type I surgery
option_2: Glucose-6-phosphate dehydrogenase deficiency surgery
option_3: Hemochromatosis surgery
option_4: Glycogen storage disease type III medical therapy
option_5: Zollinger-Ellison syndrome surgery
option_6: Glycogen storage disease type II medical therapy
option_7: Glycogen storage disease type I medical therapy